Genetic polymorphisms in NAT1 or NAT2 are associated with increased cancer risk at numerous sites (reviewed in Hein et al., 2000; Agundez, 2008) including urinary bladder (Garcia-Closas et al., 2005) and head and neck (Mohammadi et al., 2021) cancers. The gene discussed is NAT2; the disease is cancer.